These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 17949235)
1. Molecular cytogenetic characterization and diagnostics of bladder cancer. Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235 [TBL] [Abstract][Full Text] [Related]
2. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder. Krüger S; Mess F; Böhle A; Feller AC Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774 [TBL] [Abstract][Full Text] [Related]
3. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH]. Shou J; Wang M; Ma J Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593 [TBL] [Abstract][Full Text] [Related]
4. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Voorter C; Joos S; Bringuier PP; Vallinga M; Poddighe P; Schalken J; du Manoir S; Ramaekers F; Lichter P; Hopman A Am J Pathol; 1995 Jun; 146(6):1341-54. PubMed ID: 7778674 [TBL] [Abstract][Full Text] [Related]
5. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17. Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
8. Interphase cytogenetic studies of bladder cancer. Wang MR; Perissel B; Taillandier J; Malet P Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594 [TBL] [Abstract][Full Text] [Related]
9. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer]. Szarvas T Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311 [TBL] [Abstract][Full Text] [Related]
10. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality. Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360 [TBL] [Abstract][Full Text] [Related]
11. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751 [TBL] [Abstract][Full Text] [Related]
12. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226 [TBL] [Abstract][Full Text] [Related]
13. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study. Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723 [TBL] [Abstract][Full Text] [Related]
14. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer. Mahdy E; Yoshihiro S; Zech L; Wester K; Pan Y; Busch C; Döhner H; Kallioniemi O; Bergerheim U; Malmström PU Anticancer Res; 1999; 19(1A):7-12. PubMed ID: 10226518 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer. Nguyen CT; Litt DB; Dolar SE; Ulchaker JC; Jones JS; Brainard JA Urology; 2009 Feb; 73(2):347-50. PubMed ID: 19022486 [TBL] [Abstract][Full Text] [Related]
16. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer? Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805 [TBL] [Abstract][Full Text] [Related]
18. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma. Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634 [TBL] [Abstract][Full Text] [Related]
20. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder. Turyn J; Matuszewski M; Schlichtholz B Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]